TPTX » Topics » SIGNATURES

This excerpt taken from the TPTX 8-K filed Nov 3, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 


 

 

 

RAPTOR PHARMACEUTICAL CORP.


Date: November 3, 2009

 

 


By: /s/ Kim R. Tsuchimoto

 

 

Name:

Title:

Kim R. Tsuchimoto
Chief Financial Officer, Treasurer and Secretary

 

 

 

 

 

This excerpt taken from the TPTX 8-K filed Oct 9, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 


 

 

 

RAPTOR PHARMACEUTICAL CORP.


Date: October 9, 2009

 

 


By: /s/ Kim R. Tsuchimoto

 

 

Name:

Title:

Kim R. Tsuchimoto
Chief Financial Officer, Treasurer and Secretary

 

 

 

 

 

This excerpt taken from the TPTX 8-K filed Oct 7, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 


 

 

 

RAPTOR PHARMACEUTICAL CORP.


Date: October 7, 2009

 

 


By: /s/ Kim R. Tsuchimoto

 

 

Name:

Title:

Kim R. Tsuchimoto
Chief Financial Officer, Treasurer and Secretary

 

 

 

 

 

This excerpt taken from the TPTX 8-K filed Oct 5, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 


 

 

 

RAPTOR PHARMACEUTICAL CORP.


Date: October 5, 2009

 

 


By: /s/ Kim R. Tsuchimoto

 

 

Name:

Title:

Kim R. Tsuchimoto
Chief Financial Officer, Treasurer and Secretary

 

 

 

 

 

This excerpt taken from the TPTX 8-K filed Jul 31, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  TORREYPINES THERAPEUTICS, INC.
Date: July 30, 2009    
  By:  

/s/    Craig Johnson

  Name:   Craig Johnson
  Title:   Vice President, Finance and
    Chief Financial Officer


This excerpt taken from the TPTX 8-K filed Jul 28, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  TORREYPINES THERAPEUTICS, INC.
Date: July 28, 2009    
  By:  

/s/    Craig Johnson

  Name:   Craig Johnson
  Title:   Vice President, Finance and Chief Financial Officer

 


This excerpt taken from the TPTX 8-K filed Jul 22, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

        TORREYPINES THERAPEUTICS, INC.
Date: July 22, 2009      
    By:  

/s/    Craig Johnson

    Name:   Craig Johnson
    Title:   Vice President, Finance and Chief Financial Officer


This excerpt taken from the TPTX DEF 14A filed Jun 19, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: May 1, 2009

TorreyPines Therapeutics, Inc.
By: /s/ Evelyn A. Graham
 

Evelyn A. Graham

Chief Executive Officer

(Principal Executive Officer)

By: /s/ Craig Johnson
 

Craig Johnson

Vice President, Finance

Chief Financial Officer, and Secretary

(Principal Financial and Accounting Officer)

 

29


Table of Contents

TORREYPINES THERAPEUTICS, INC.

This excerpt taken from the TPTX 8-K filed Jun 17, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

      TORREYPINES THERAPEUTICS, INC.
Date: June 17, 2009      
      By:  

/s/    Paul Schneider

      Name:   Paul Schneider
      Title:   Vice President and General Counsel
This excerpt taken from the TPTX DEFA14A filed May 29, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

      TORREYPINES THERAPEUTICS, INC.
Date: May 29, 2009      
      By:  

/s/    Craig Johnson

      Name:   Craig Johnson
      Title:   Vice President, Finance and
        Chief Financial Officer


Exhibit No.

 

Description

99.1   Press release of the Company dated May 29, 2009 – “TorreyPines Therapeutics, Inc. Announces its Board of Directors’ Approval of Plan of Liquidation and Dissolution by Board of Directors.”
This excerpt taken from the TPTX 8-K filed May 29, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

      TORREYPINES THERAPEUTICS, INC.
Date: May 29, 2009      
      By:  

/s/    Craig Johnson

      Name:   Craig Johnson
      Title:   Vice President, Finance and
        Chief Financial Officer


Exhibit No.

 

Description

99.1   Press release of the Company dated May 29, 2009 – “TorreyPines Therapeutics, Inc. Announces its Board of Directors’ Approval of Plan of Liquidation and Dissolution by Board of Directors.”
This excerpt taken from the TPTX 8-K filed May 1, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    TORREYPINES THERAPEUTICS, INC.
Date: May 1, 2009     By:   /s/ Craig Johnson
      Name:   Craig Johnson
      Title:   Vice President, Finance and Chief Financial Officer


This excerpt taken from the TPTX 10-Q filed May 1, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: May 1, 2009

TorreyPines Therapeutics, Inc.
By: /s/ Evelyn A. Graham
 

Evelyn A. Graham

Chief Executive Officer

(Principal Executive Officer)

By: /s/ Craig Johnson
 

Craig Johnson

Vice President, Finance

Chief Financial Officer, and Secretary

(Principal Financial and Accounting Officer)

 

29

This excerpt taken from the TPTX 8-K filed Apr 24, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  TORREYPINES THERAPEUTICS, INC.
Date: April 23, 2009    
  By:  

/s/    Craig Johnson

  Name:   Craig Johnson
  Title:   Vice President, Finance and Chief Financial Officer
This excerpt taken from the TPTX 8-K filed Apr 2, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    TORREYPINES THERAPEUTICS, INC.
  Date: April 2, 2009     By:   /s/ Craig Johnson
      Name:   Craig Johnson
      Title:   Vice President, Finance and
        Chief Financial Officer


This excerpt taken from the TPTX 8-K filed Mar 31, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    TORREYPINES THERAPEUTICS, INC.
  Date: March 31, 2009     By:   /s/ Craig Johnson
      Name:   Craig Johnson
      Title:  

Vice President, Finance and

Chief Financial Officer


These excerpts taken from the TPTX 10-K filed Mar 27, 2009.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

TORREYPINES THERAPEUTICS, INC.
By:   /s/    EVELYN A. GRAHAM        
 

Evelyn A. Graham,

Chief Executive Officer

Date: March 27, 2009

KNOW ALL PERSONS BY THESE PRESENTS, that each individual whose signature appears below constitutes and appoints Evelyn A. Graham and Craig Johnson, and each of them, his true and lawful attorneys-in-fact and agents with full power of substitution, for him and in his name, place and stead, in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto and all documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or any of them, or his or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

Signature

 

Title

 

Date

/s/    EVELYN A. GRAHAM        

Evelyn A. Graham

 

Chief Executive Officer and Director

(Principal Executive Officer)

  March 25, 2009

/s/    CRAIG JOHNSON        

Craig Johnson

 

Vice President, Finance and
Chief Financial Officer

(Principal Financial and Accounting Officer)

  March 25, 2009

/s/    PETER DAVIS, PH.D.        

Peter Davis, Ph.D.

  Director   March 25, 2009

/s/    JEAN DELEAGE, PH.D.        

Jean Deleage, Ph.D.

  Director   March 25, 2009

/s/    STEVEN H. FERRIS, PH.D.        

Steven H. Ferris, Ph.D.

  Director   March 25, 2009

/s/    JASON FISHERMAN, M.D        

Jason Fisherman, M.D

  Director   March 25, 2009

/s/    STEVEN B. RATOFF        

Steven B. Ratoff

  Director   March 25, 2009

/s/    PATRICK VAN BENEDEN        

Patrick Van Beneden

  Director   March 25, 2009

 

70


Table of Contents

TorreyPines Therapeutics, Inc.

SIGNATURES

STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed
on its behalf by the undersigned, thereunto duly authorized.

 





















TORREYPINES THERAPEUTICS, INC.
By: /s/    EVELYN A. GRAHAM        
 

Evelyn A. Graham,

FACE="Times New Roman" SIZE="1">Chief Executive Officer

Date: March 27, 2009

FACE="Times New Roman" SIZE="2">KNOW ALL PERSONS BY THESE PRESENTS, that each individual whose signature appears below constitutes and appoints Evelyn A. Graham and Craig Johnson, and each of them, his true and lawful attorneys-in-fact and agents
with full power of substitution, for him and in his name, place and stead, in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto and all documents in
connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and
about the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or any of them, or his or their substitute or substitutes, may lawfully do or
cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below
by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 
































































































Signature

 

Title

 

Date

/s/    EVELYN A.
GRAHAM        

Evelyn A. Graham

 

Chief Executive Officer and Director

(Principal
Executive Officer)

 March 25, 2009

/s/    CRAIG
JOHNSON        

Craig Johnson

 

Vice President, Finance and
Chief Financial Officer

SIZE="2">(Principal Financial and Accounting Officer)

 March 25, 2009

/s/    PETER DAVIS,
PH.D.        

Peter Davis, Ph.D.

 Director March 25, 2009

/s/    JEAN DELEAGE,
PH.D.        

Jean Deleage, Ph.D.

 Director March 25, 2009

/s/    STEVEN H. FERRIS,
PH.D.        

Steven H. Ferris, Ph.D.

 Director March 25, 2009

/s/    JASON FISHERMAN,
M.D        

Jason Fisherman, M.D

 Director March 25, 2009

/s/    STEVEN B.
RATOFF        

Steven B. Ratoff

 Director March 25, 2009

/s/    PATRICK VAN
BENEDEN        

Patrick Van Beneden

 Director March 25, 2009

 


70







Table of Contents


TorreyPines Therapeutics, Inc.

STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center">Index to Consolidated Financial Statements

 




































   Page

Report of Independent Registered Public Accounting Firm

  F-2

Consolidated Balance Sheets as of December 31, 2008 and 2007

  F-3

Consolidated Statements of Operations for the Years Ended December 31, 2008, 2007 and 2006

  F-4

Consolidated Statements of Stockholders’ Equity (Deficit) for the Years Ended December 31, 2008, 2007 and
2006

  F-5

Consolidated Statements of Cash Flows for the Years Ended December 31, 2008, 2007 and 2006

  F-6

Notes to Consolidated Financial Statements

  F-7

 


F-1







Table of Contents


This excerpt taken from the TPTX 8-K filed Mar 27, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    TORREYPINES THERAPEUTICS, INC.
Date: March 27, 2009     By:   /s/ Craig Johnson
    Name:   Craig Johnson
    Title:   Vice President, Finance and Chief Financial Officer


This excerpt taken from the TPTX 8-K filed Feb 9, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    TORREYPINES THERAPEUTICS, INC.
Date: February 9, 2009     By:   /s/ Craig Johnson
    Name:   Craig Johnson
    Title:   Vice President, Finance and Chief Financial Officer
This excerpt taken from the TPTX 8-K filed Dec 2, 2008.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    TORREYPINES THERAPEUTICS, INC.
Date: December 2, 2008      
    By:   /s/ Craig Johnson
      Name: Craig Johnson
      Title: Vice President, Finance and Chief Financial Officer


This excerpt taken from the TPTX 8-K filed Dec 1, 2008.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    TORREYPINES THERAPEUTICS, INC.

Date: December 1, 2008

    By:   /s/ Craig Johnson
    Name:   Craig Johnson
    Title:   Vice President, Finance and
      Chief Financial Officer


This excerpt taken from the TPTX 8-K filed Nov 26, 2008.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    TORREYPINES THERAPEUTICS, INC.
Date: November 26, 2008    
    By:   /s/ Craig Johnson
      Name:   Craig Johnson
      Title:  

Vice President, Finance and

Chief Financial Officer


This excerpt taken from the TPTX 10-Q filed Nov 12, 2008.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: November 12, 2008

 

TorreyPines Therapeutics, Inc.
By:   /s/ Evelyn Graham

Evelyn Graham

Acting Chief Executive Officer

(Principal Executive Officer)

By:   /s/ Craig Johnson

Craig Johnson

Vice President, Finance

Chief Financial Officer, and Secretary

(Principal Financial and Accounting Officer)

 

30

This excerpt taken from the TPTX 8-K filed Nov 12, 2008.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  TORREYPINES THERAPEUTICS, INC.
Date: November 12, 2008   By:  

/s/    Craig Johnson

  Name:   Craig Johnson
  Title:   Vice President, Finance and
    Chief Financial Officer


Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki